Skip to content

A study to compare the effects of Dexamethasone and Dexmedetomidine when added to local anesthetics for pain relief during upper limb surgeries using an ultrasound-guided nerve block.

A Study comparing Dexamethasone and Dexmedetomidine as adjuvants with Bupivacaine and Lignocaine and Adrenaline in Ultrasound guided Supraclavicular Brachial plexus block - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091909
Enrollment
98
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: G540- Brachial plexus disorders

Interventions

Intervention1: Dexamethasone as adjuvants with Bupivacaine and Lignocaine with Adrenaline: 10 ml of 2% Lignocaine + 10 ml of 0.5% Bupivacaine + 0.1 ml Adrenaline 1:1000 + 4 mg Dexamethasone Control In

Sponsors

Dr KOUSIKA K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 18 to 65 years undergoing elective upper limb surgeries under Ultrasound guided supraclavicular brachial plexus block. 2. Patients classified as American Society of Anesthesiologists physical status I or II. 3. Patients willing to undergo Ultrasound-guided supraclavicular brachial plexus block. 4. Patients who provide written informed consent for participation in the study. 5. Patients with normal coagulation profile PT,APTT ,no bleeding diasthesis, platelet count more than 1 lakh and no contraindication to regional anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with known allergy or hypersensitivity to local anesthetics,Adrenaline, Dexamethasone, or Dexmedetomidine. 2. Patients with coagulopathy or on anticoagulant therapy. 3. Patients with infection at the site of block or local skin infections Abscess, Hematoma, Folliculitis, Impetigo etc 4. Patients with pre-existing neurological deficits in the upper limb to be operated. 5. Patients with cardiopulmonary disease e.g., uncontrolled hypertension, ischemic heart disease, heart failure, COPD. 6. Pregnant or lactating women. 7. BMI more than 40 kg per m morbid obesity making ultrasound-guided block difficult.

Design outcomes

Primary

MeasureTime frame
1.To compare the onset time of sensory and motor blockade. 2.To compare the duration of sensory and motor blockade. 3.To evaluate the incidence and type of adverse drug reactions associated with each adjuvant. Timepoint: 0 hour 15min 30min 45min 60min 90min 120min 3hour 4 hour 5 hour 6 hour 7 hour 8 hour 9 hour 10 hour 11 hour TILL VAS MORE THAN OR EQUALTO 4

Secondary

MeasureTime frame
1.To compare the pharmacological interactions between local anesthetics and Dexmedetomidine and Dexamethasone in producing neuronal blockade. 2.To assess the hemodynamic effects as indicators of systemic pharmacological effects of Dexamethasone and Dexmedetomidine Timepoint: 0 hour 15min 30min 45min 60min 90min 120min 3hour 4 hour 5 hour 6 hour 7 hour 8 hour 9 hour 10 hour 11 hour TILL VAS SCORE MORE THAN 4

Countries

India

Contacts

Public ContactDr KOUSIKA K

Professor & HOD, Department of Pharmacology, SABVMCRI, Bengaluru, Karnataka, India

nskargk97@gmail.com8072982193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026